Related Experiment Videos
Target blood pressure in elderly hypertensive patients: how low should you go?
1Centro di Fisiologia Clinica e Ipertensione, Università di Milano, Ospedale Maggiore and Istituto Auxologico Italiano, Milan, Italy.
Insights
Hypertension is rising in older adults, increasing cardiovascular risk. Antihypertensive treatment, especially intensive therapy, effectively lowers blood pressure and reduces cardiovascular events in the elderly.
Area of Science:
- Cardiology
- Geriatrics
- Pharmacology
Background:
- Hypertension prevalence increases with age, elevating cardiovascular disease (CVD) risk.
- Antihypertensive treatment in elderly patients significantly reduces cardiovascular mortality and morbidity.
- Treatment benefits correlate with the degree of blood pressure reduction.
Purpose of the Study:
- To review the efficacy and safety of antihypertensive therapies in elderly patients.
- To discuss current guidelines for blood pressure management in older adults.
- To introduce angiotensin II type 1 receptor antagonists as a therapeutic option.
Main Methods:
- Analysis of epidemiological data and randomized controlled trials (RCTs).
- Review of findings from the Hypertension Optimal Treatment (HOT) Study.
- Examination of ongoing trials like the Study on Cognition and Prognosis in the Elderly (SCOPE).
Main Results:
- Intensive antihypertensive therapy yields greater blood pressure reduction in elderly patients without increased adverse events.
- Current guidelines recommend targeting high-normal blood pressure (below 140/90 mmHg) in elderly patients.
- Angiotensin II type 1 receptor antagonists are being investigated for their cardiovascular impact in this population.
Conclusions:
- Aggressive blood pressure control is crucial for reducing cardiovascular risk in the elderly.
- Newer agents like angiotensin II type 1 receptor antagonists show promise for managing hypertension in older adults.
- Ongoing research, such as SCOPE, will further elucidate the long-term benefits of these treatments.
Abstract:
Epidemiological studies have highlighted the increasing prevalence of hypertension with age, and the associated increase in the risk of cardiovascular disease. A number of randomized controlled trials have shown that antihypertensive treatment significantly reduces cardiovascular mortality and morbidity in elderly patients, and there is evidence that the benefit achieved is related to the extent to which blood pressure is lowered. Furthermore, a recent analysis of data from the Hypertension Optimal Treatment (HOT) Study shows that intensive therapy produces significantly greater reductions in blood pressure in elderly patients than in younger patients, without increasing the risk of adverse events. As a result, the latest management guidelines recommend that the goal of antihypertensive therapy in elderly patients should be to achieve at least high normal blood pressures (below 140/90 mmHg). Angiotensin II type 1 receptor antagonists offer a new option for antihypertensive therapy in elderly patients, and trials such as the Study on Cognition and Prognosis in the Elderly (SCOPE) are currently investigating the effect of these agents on cardiovascular mortality and morbidity in elderly hypertensive patients.